Circulating exosomal PD-L1 at initial diagnosis predicts outcome and survival of patients with osteosarcoma.
Jun WangWei GuoXiaofang WangXiaodong TangXin SunTingting RenPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Use of liquid biopsy of circulating exosomal PD-L1 at initial diagnosis provides a robust means of predicting prognosis for patients with a newly diagnosed osteosarcoma.